![](https://unicorn-nest.com/wp-content/uploads/2021/11/Otsuka-Pharmaceutical.jpg?x55332)
Related Funds
Fund Name | Location |
101 Startups | Barcelona, Catalonia, Spain |
Alexa Next Stage, powered by Techstars | - |
American Industrial Partners | New York, New York, United States |
Bohong Jijin | China, Guangdong, Shenzhen |
Collins Community Credit Union | Cedar Rapids, Iowa, United States |
Contents innovation Program | Japan, Tokyo |
Crossfire Holdings | - |
Jiaxing Xiaoyuan Chuangye Touzi Hehuo Qiye | China, Jiaxing, Zhejiang |
JP Asia Capital Partners | Central, Central Region, Singapore |
Livesense | Japan, Tokyo |
M5Invest Partners | Pennsylvania, United States, Villanova |
Mingde Zhiyuan Touzi | China, Guangdong, Tianjin |
Neusoft Group | China, Liaoning, Shenyang |
Pimpernel Holdings | - |
Portag3 Ventures | Canada, Ontario, Toronto |
RevRoad | Provo, United States, Utah |
Siam Alpha Equity | - |
Taiwan Special Opportunities Fund III | - |
Tudor Growth Equity | Boston, Massachusetts, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
VIE STYLE | $2M | 07 Mar 2024 | Kamakura, Kanagawa Prefecture, Japan | ||
Atmo Biosciences | $8M | 30 Mar 2023 | Melbourne, Victoria, Australia | ||
OE Therapeutics | $26M | 03 Aug 2022 | New Haven, Connecticut, United States | ||
Renascience | $455K | 11 Mar 2019 | Chiyoda | ||
Megakaryon Corporation | $33M | 25 Dec 2017 | Kyoto, Kyoto Prefecture, Japan |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
VIE STYLE | $2M | 07 Mar 2024 | Kamakura, Kanagawa Prefecture, Japan | ||
Atmo Biosciences | $8M | 30 Mar 2023 | Melbourne, Victoria, Australia | ||
OE Therapeutics | $26M | 03 Aug 2022 | New Haven, Connecticut, United States | ||
Renascience | $455K | 11 Mar 2019 | Chiyoda | ||
Megakaryon Corporation | $33M | 25 Dec 2017 | Kyoto, Kyoto Prefecture, Japan |